文献检索，用中文搜 PubMed

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

Reinhardt M A, Nelson S C, Sencer S F, Bostrom B C, Kurachek S C, Nesbit M E

Department of Pediatrics, University of Minnesota Hospitals and Clinics, Minneapolis, USA.

J Pediatr Hematol Oncol. 1997 May-Jun;19(3):232-6. doi: 10.1097/00043426-199705000-00010.

PURPOSE

Nonsurgical treatment of lymphangiomas has shown limited efficacy and often carries unacceptable toxicities, demonstrating the need for a more effective, less toxic therapy.

PATIENTS AND METHODS

We describe two patients with lymphangiomatosis treated for 12 to 40 months with recombinant interferon-alpha.

RESULTS

Both patients demonstrated stabilization or marked improvement of disease, based on clinical and radiologic findings, with minimal toxicity.

CONCLUSIONS

The favorable responses to interferon-alpha therapy in these two cases suggest that this is an effective and well-tolerated treatment for lymphangiomas in children.

相似文献

Treatment of childhood lymphangiomas with interferon-alpha.

J Pediatr Hematol Oncol. 1997 May-Jun;19(3):232-6. doi: 10.1097/00043426-199705000-00010.

Splenic lymphangioma.脾淋巴管瘤。

Arch Pathol Lab Med. 2015 Feb;139(2):278-82. doi: 10.5858/arpa.2013-0656-RS.

Thoracic lymphangiomas, lymphangiectasis, lymphangiomatosis, and lymphatic dysplasia syndrome.胸段淋巴管瘤、淋巴管扩张症、淋巴管瘤病及淋巴发育异常综合征。

Am J Respir Crit Care Med. 2000 Mar;161(3 Pt 1):1037-46. doi: 10.1164/ajrccm.161.3.9904056.

Phase II trial of interferon-beta-serine in metastatic renal cell carcinoma.

J Clin Oncol. 1990 May;8(5):881-5. doi: 10.1200/JCO.1990.8.5.881.

[Assessment of the formation of antibodies to interferon in patients with juvenile respiratory papillomatosis on interferon therapy].

Vestn Otorinolaringol. 1996 Jul-Aug(4):25-7.

Lymphangiomatosis of the spine: two cases requiring surgical intervention.脊柱淋巴管瘤病：两例需要手术干预的病例。

Spine (Phila Pa 1976). 2003 Feb 1;28(3):E45-50. doi: 10.1097/01.BRS.0000042235.41817.04.

[Clinical experience with alpha and beta interferon in childhood cancer].[α和β干扰素在儿童癌症中的临床经验]

Gan To Kagaku Ryoho. 1984 Sep;11(9):1855-62.

[Lymphangioma and lymphangiectasia].[淋巴管瘤和淋巴管扩张症]

Rev Pneumol Clin. 2013 Oct;69(5):272-7. doi: 10.1016/j.pneumo.2013.04.002. Epub 2013 May 18.

OK-432 therapy of lymphangiomas in children.OK-432治疗儿童淋巴管瘤

Eur J Pediatr. 1996 Aug;155(8):649-52. doi: 10.1007/BF01957145.

Sclerosing treatment of lymphangiomas with OK-432.用OK-432对淋巴管瘤进行硬化治疗。

Arch Dis Child. 2000 Apr;82(4):316-8. doi: 10.1136/adc.82.4.316.

引用本文的文献

A Primer on a Comprehensive Genetic Approach to Vascular Anomalies.血管异常综合遗传方法入门

Front Pediatr. 2020 Oct 19;8:579591. doi: 10.3389/fped.2020.579591. eCollection 2020.

Hemorrhagic shock from post-traumatic rupture of microcystic splenic lymphangioma: A case report and review of the literature.创伤后微囊性脾淋巴管瘤破裂导致的失血性休克：一例报告并文献复习

Int J Surg Case Rep. 2020;75:376-379. doi: 10.1016/j.ijscr.2020.09.045. Epub 2020 Sep 10.

Rare cystic lymphangioma in the chest wall of an adult patient: A case report and comprehensive review of the literature.

Reinhardt M A, Nelson S C, Sencer S F, Bostrom B C, Kurachek S C, Nesbit M E

Department of Pediatrics, University of Minnesota Hospitals and Clinics, Minneapolis, USA.

J Pediatr Hematol Oncol. 1997 May-Jun;19(3):232-6. doi: 10.1097/00043426-199705000-00010.

PURPOSE

Nonsurgical treatment of lymphangiomas has shown limited efficacy and often carries unacceptable toxicities, demonstrating the need for a more effective, less toxic therapy.

PATIENTS AND METHODS

We describe two patients with lymphangiomatosis treated for 12 to 40 months with recombinant interferon-alpha.

RESULTS

Both patients demonstrated stabilization or marked improvement of disease, based on clinical and radiologic findings, with minimal toxicity.

CONCLUSIONS

The favorable responses to interferon-alpha therapy in these two cases suggest that this is an effective and well-tolerated treatment for lymphangiomas in children.